False-Positive Results and Incidental Findings with Annual CT or PET/CT Surveillance in Asymptomatic Patients with Resected Stage III Melanoma-Reference-Cited by-同舟云学术

False-Positive Results and Incidental Findings with Annual CT or PET/CT Surveillance in Asymptomatic Patients with Resected Stage III Melanoma

Published:2019-03-25 Issue:6 Volume:26 Page:1860-1868
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Nijhuis Amanda A. G.,Dieng Mbathio,Khanna Nikita,Lord Sally J.,Dalton Jo,Menzies Alexander M.,Turner Robin M.,Allen Jay,Saw Robyn P. M.,Nieweg Omgo E.,Thompson John F.,Morton Rachael L.

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

http://link.springer.com/content/pdf/10.1245/s10434-019-07311-0.pdf

Reference45 articles.

1. Gershenwald JE, Scolyer RA, Hess KR, et al. Melanoma staging: evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017;67(6):472–492

2. DeRose ER, Pleet A, Wang W, et al. Utility of 3-year torso computed tomography and head imaging in asymptomatic patients with high-risk melanoma. Melanoma Res. 2011;21:364–369

3. Romano E, Scordo M, Dusza SW, et al. Site and timing of first relapse in stage III melanoma patients: Implications for follow-up guidelines. J Clin Oncol. 2010;28:3042–3047

4. Leiter U, Buettner PG, Eigentler TK, et al. Is detection of melanoma metastasis during surveillance in an early phase of development associated with a survival benefit? Melanoma Res. 2010;20:240–6

5. Moschetti I, Cinquini M, Lambertini M, et al. Follow-up strategies for women treated for early breast cancer. Cochrane Database Syst Rev. 2016;(5):CD001768.

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanocomposite hydrogels in skin cancer medicine;Neoplasma;2024

2. Role of Concurrent Ultrasound Surveillance of Sentinel Node-Positive Node Fields in Melanoma Patients Having Routine Cross-Sectional Imaging;Annals of Surgical Oncology;2023-11-15

3. Fallstricke bei der Einordnung von FDG‐PET/CT‐Befunden bei Melanompatienten – eine Fallserie;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2023-08

4. Pitfalls in evaluating FDG‐PET/CT results in melanoma patients – A case series;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2023-05

5. Circulating tumor DNA‐based molecular residual disease detection for treatment monitoring in advanced melanoma patients;Cancer;2023-03-04